Kannan Natarajan Selected Research

CD8alphabeta antigen

8/2009

Structural basis of the CD8 alpha beta/MHC class I interaction: focused recognition orients CD8 beta to a T cell proximal position.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kannan Natarajan Research Topics

Disease

4	Pulmonary Embolism 01/2021 - 08/2015
3	Thrombosis (Thrombus) 01/2021 - 08/2015
3	Neoplasms (Cancer) 01/2020 - 01/2002
2	Hemorrhage 01/2021 - 08/2015
2	Inflammation (Inflammations) 01/2020 - 01/2018
2	Hypersensitivity (Allergy) 01/2020 - 01/2018
2	Autoimmune Diseases (Autoimmune Disease) 12/2008 - 04/2004
1	Dementia (Dementias) 09/2021
1	Hemangioma (Angioma) 01/2021
1	Persistent Infection 01/2020
1	Gram-Positive Bacterial Infections 01/2020
1	Chemical and Drug Induced Liver Injury 01/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 04/2019
1	Drug-Related Side Effects and Adverse Reactions 01/2018
1	Hypotension (Low Blood Pressure) 08/2015
1	Hematoma 08/2015
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 08/2015
1	Pulmonary Hypertension 08/2015
1	Candidiasis (Moniliasis) 09/2013
1	Uveitis 08/2013
1	Infections 12/2012
1	Carcinogenesis 12/2012
1	Septic Shock (Toxic Shock Syndrome) 01/2011
1	Shock 06/2010
1	Foodborne Diseases 06/2010
1	X-Linked Syndrome Enteropathy Polyendocrinopathy Immune Dysregulation 05/2010
1	Acquired Immunodeficiency Syndrome (AIDS) 08/2009
1	Malaria 08/2009
1	Tuberculosis (Tuberculoses) 08/2009
1	Gastritis 12/2008
1	Rheumatoid Arthritis 09/2005
1	Chronic Kidney Failure (Chronic Renal Failure) 08/2005
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 04/2004
1	Multiple Sclerosis 04/2004
1	Ischemic Stroke 01/2004
1	Coronary Disease (Coronary Heart Disease) 01/2004
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2004
1	Myocardial Infarction 01/2004

Drug/Important Bio-Agent (IBA)

2	Peptides (Polypeptides)IBA 01/2020 - 12/2008
2	HLA-B57 antigenIBA 01/2020 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2018
2	VaccinesIBA 01/2020 - 08/2009
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2018 - 08/2015
2	LigandsIBA 12/2012 - 01/2002
2	staphylococcal enterotoxin BIBA 01/2011 - 06/2010
1	Cholinergic Antagonists (Anticholinergics)IBA 09/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Floxacillin (Flucloxacillin)IBA 01/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	LactamsIBA 01/2020
1	abacavir (Ziagen)FDA Link 01/2018
1	HIV Reverse TranscriptaseIBA 01/2018
1	Streptokinase FDA Link 08/2015
1	SteroidsIBA 09/2013
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 08/2013
1	interstitial retinol-binding proteinIBA 08/2013
1	NK Cell Lectin-Like Receptor Subfamily KIBA 12/2012
1	AntibodiesIBA 01/2011
1	SuperantigensIBA 01/2011
1	CytokinesIBA 01/2011
1	HLA-DR3 Antigen (HLA DR3 Antigen)IBA 01/2011
1	ExotoxinsIBA 06/2010
1	Biological Warfare AgentsIBA 06/2010
1	AntigensIBA 05/2010
1	Keratin-14 (Keratin 14)IBA 05/2010
1	CD8alphabeta antigenIBA 08/2009
1	EpitopesIBA 12/2008
1	Abatacept (Orencia)FDA Link 09/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2005
1	Antirheumatic Agents (DMARD)IBA 09/2005
1	Myelin-Oligodendrocyte GlycoproteinIBA 04/2004
1	AutoantigensIBA 04/2004
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2004
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2004
1	Pravastatin (Pravachol)FDA LinkGeneric 01/2004

Therapy/Procedure

5	Catheters 01/2021 - 08/2015
2	Therapeutics 01/2021 - 09/2005
1	Polypharmacy 09/2021
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2021
1	Immunotherapy 08/2009
1	Kidney Transplantation 08/2005
1	Secondary Prevention 01/2004
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2004